Rockwell Collins to Sell Kaiser Optical Systems to Endress+Hauser - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Rockwell Collins to Sell Kaiser Optical Systems to Endress+Hauser



Rockwell Collins announced that it has agreed to sell its subsidiary, Kaiser Optical Systems, a spectrographic instrumentation and applied holographic technology company, to Endress+Hauser, a producer of measurement instrumentation and services for industrial process engineering. Terms of the agreement were not disclosed. The sale is expected to be complete in early fiscal 2014 and is subject to customary closing conditions.

Kaiser Optical Systems, located in Ann Arbor, Michigan, became a Rockwell Collins company in 2000 as part of the company’s purchase of K Systems, the parent company of Kaiser Aerospace and Electronics. Principal products include Raman sensors and instrumentation, advanced holographic components for
spectroscopy, telecommunications, astronomy and ultra-fast sciences, and components for aircraft display systems.

Source: Rockwell Collins

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here